Hepatopulmonary syndrome other diagnostic studies: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| (2 intermediate revisions by the same user not shown) | |||
| Line 3: | Line 3: | ||
{{CMG}}; {{AE}} {{Soroush}} | {{CMG}}; {{AE}} {{Soroush}} | ||
==Overview== | ==Overview== | ||
'''Pulmonary function tests''' may be helpful in the diagnosis of hepatopulmonary syndrome. Findings suggestive of hepatopulmonary syndrome include A decrease in the single-breath diffusing capacity for carbon monoxide (DLCO) suggesting a diffusion impairment as | '''Pulmonary function tests''' may be helpful in the diagnosis of hepatopulmonary syndrome. Findings suggestive of hepatopulmonary syndrome include A decrease in the single-breath [[DLCO|diffusing capacity for carbon monoxide (DLCO)]] suggesting a diffusion impairment as a frequent finding in hepatopulmonary syndrome (occurring in up to 80% of patients). '''Six minute walk test with and without an oxygen titration''' can also use as an objective assessment of exercise capacity. | ||
==Other Diagnostic Studies== | ==Other Diagnostic Studies== | ||
'''Pulmonary Function Tests''' | '''Pulmonary Function Tests''' | ||
| Line 11: | Line 12: | ||
* Usually PFT in HPS patients usually reveal normal flows and lung volumes, | * Usually PFT in HPS patients usually reveal normal flows and lung volumes, | ||
* Pulmonary function testing (PFT) may be helpful in the diagnosis of hepatopulmonary syndrome. | * Pulmonary function testing ([[Spirometry|PFT]]) may be helpful in the diagnosis of hepatopulmonary syndrome. | ||
* Findings suggestive of hepatopulmonary syndrome include: | * Findings suggestive of hepatopulmonary syndrome include: | ||
| Line 17: | Line 18: | ||
*''Nevertheless this finding is frequent in people with cirrhosis who do not have HPS as well,'' ''(50-70% of cirrhotic patients)'' | *''Nevertheless this finding is frequent in people with cirrhosis who do not have HPS as well,'' ''(50-70% of cirrhotic patients)'' | ||
*A decrease in the single-breath diffusing capacity for carbon monoxide (DLCO) (not specific) is the most prevalent finding. | *A decrease in the single-breath diffusing capacity for carbon monoxide (DLCO) (not specific) is the most prevalent finding. | ||
*A mean DLCO of 55% predicted in HPS patients compared to a mean of 72% predicted in people with cirrhosis who do not have HPS . | *A mean [[DLCO]] of 55% predicted in HPS patients compared to a mean of 72% predicted in people with cirrhosis who do not have HPS . | ||
*Reduced lung volumes might barely observed in tense ascites or in the presence of pleural | *Reduced lung volumes might barely be observed in tense ascites or in the presence of [[pleural effusion]]<nowiki/>s due to [[oncotic pressure]] disturbance or other reasons. (neither [[Specificity (tests)|specific]] nor [[Sensitivity (tests)|sensitive]]) | ||
'''Six Minute Walk Test With and Without an Oxygen Titration''' | '''Six Minute Walk Test With and Without an Oxygen Titration''' | ||
| Line 25: | Line 26: | ||
* A decrease below 88% O2 saturation with exertion calls for an oxygen titration study to identify and match oxygen requirements. | * A decrease below 88% O2 saturation with exertion calls for an oxygen titration study to identify and match oxygen requirements. | ||
<ref name="pmid18509123">Rodríguez-Roisin R, Krowka MJ (2008) [https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=18509123 Hepatopulmonary syndrome--a liver-induced lung vascular disorder.] ''N Engl J Med'' 358 (22):2378-87. [http://dx.doi.org/10.1056/NEJMra0707185 DOI:10.1056/NEJMra0707185] PMID: [https://pubmed.gov/18509123 18509123]</ref> | |||
<ref name="pmid11003635">Fallon MB, Abrams GA (2000) [https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=11003635 Pulmonary dysfunction in chronic liver disease.] ''Hepatology'' 32 (4 Pt 1):859-65. [http://dx.doi.org/10.1053/jhep.2000.7519 DOI:10.1053/jhep.2000.7519] PMID: [https://pubmed.gov/11003635 11003635]</ref> | |||
<ref name="pmid14762853">Krowka MJ, Mandell MS, Ramsay MA, Kawut SM, Fallon MB, Manzarbeitia C et al. (2004) [https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=14762853 Hepatopulmonary syndrome and portopulmonary hypertension: a report of the multicenter liver transplant database.] ''Liver Transpl'' 10 (2):174-82. [http://dx.doi.org/10.1002/lt.20016 DOI:10.1002/lt.20016] PMID: [https://pubmed.gov/14762853 14762853]</ref> | |||
<ref name="pmid891282">Kennedy TC, Knudson RJ (1977) [https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=891282 Exercise-aggravated hypoxemia and orthodeoxia in cirrhosis.] ''Chest'' 72 (3):305-9. [http://dx.doi.org/10.1378/chest.72.3.305 DOI:10.1378/chest.72.3.305] PMID: [https://pubmed.gov/891282 891282]</ref> | |||
<ref name="pmid27326810">Krowka MJ, Fallon MB, Kawut SM, Fuhrmann V, Heimbach JK, Ramsay MA et al. (2016) [https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=27326810 International Liver Transplant Society Practice Guidelines: Diagnosis and Management of Hepatopulmonary Syndrome and Portopulmonary Hypertension.] ''Transplantation'' 100 (7):1440-52. [http://dx.doi.org/10.1097/TP.0000000000001229 DOI:10.1097/TP.0000000000001229] PMID: [https://pubmed.gov/27326810 27326810]</ref> | |||
==References== | ==References== | ||
| Line 31: | Line 38: | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
[[Category: | [[Category:Surgery]] | ||
[[Category:Medicine]] | |||
[[Category:Pulmonology]] | |||
[[Category:Cardiology]] | |||
[[Category:Gastroentrology]] | |||
[[Category:Up-To-Date]] | |||
Latest revision as of 18:02, 6 September 2019
|
Hepatopulmonary syndrome Microchapters |
|
Differentiating Hepatopulmonary syndrome from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Hepatopulmonary syndrome other diagnostic studies On the Web |
|
American Roentgen Ray Society Images of Hepatopulmonary syndrome other diagnostic studies |
|
Hepatopulmonary syndrome other diagnostic studies in the news |
|
Risk calculators and risk factors for Hepatopulmonary syndrome other diagnostic studies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Soroush Seifirad, M.D.[2]
Overview
Pulmonary function tests may be helpful in the diagnosis of hepatopulmonary syndrome. Findings suggestive of hepatopulmonary syndrome include A decrease in the single-breath diffusing capacity for carbon monoxide (DLCO) suggesting a diffusion impairment as a frequent finding in hepatopulmonary syndrome (occurring in up to 80% of patients). Six minute walk test with and without an oxygen titration can also use as an objective assessment of exercise capacity.
Other Diagnostic Studies
Pulmonary Function Tests
- Usually PFT in HPS patients usually reveal normal flows and lung volumes,
- Pulmonary function testing (PFT) may be helpful in the diagnosis of hepatopulmonary syndrome.
- Findings suggestive of hepatopulmonary syndrome include:
- Diffusion impairment is a frequent finding in HPS, occurring in up to 80% of patients.
- Nevertheless this finding is frequent in people with cirrhosis who do not have HPS as well, (50-70% of cirrhotic patients)
- A decrease in the single-breath diffusing capacity for carbon monoxide (DLCO) (not specific) is the most prevalent finding.
- A mean DLCO of 55% predicted in HPS patients compared to a mean of 72% predicted in people with cirrhosis who do not have HPS .
- Reduced lung volumes might barely be observed in tense ascites or in the presence of pleural effusions due to oncotic pressure disturbance or other reasons. (neither specific nor sensitive)
Six Minute Walk Test With and Without an Oxygen Titration
- Objective assessment of exercise capacity
- A decrease below 88% O2 saturation with exertion calls for an oxygen titration study to identify and match oxygen requirements.
References
- ↑ Rodríguez-Roisin R, Krowka MJ (2008) Hepatopulmonary syndrome--a liver-induced lung vascular disorder. N Engl J Med 358 (22):2378-87. DOI:10.1056/NEJMra0707185 PMID: 18509123
- ↑ Fallon MB, Abrams GA (2000) Pulmonary dysfunction in chronic liver disease. Hepatology 32 (4 Pt 1):859-65. DOI:10.1053/jhep.2000.7519 PMID: 11003635
- ↑ Krowka MJ, Mandell MS, Ramsay MA, Kawut SM, Fallon MB, Manzarbeitia C et al. (2004) Hepatopulmonary syndrome and portopulmonary hypertension: a report of the multicenter liver transplant database. Liver Transpl 10 (2):174-82. DOI:10.1002/lt.20016 PMID: 14762853
- ↑ Kennedy TC, Knudson RJ (1977) Exercise-aggravated hypoxemia and orthodeoxia in cirrhosis. Chest 72 (3):305-9. DOI:10.1378/chest.72.3.305 PMID: 891282
- ↑ Krowka MJ, Fallon MB, Kawut SM, Fuhrmann V, Heimbach JK, Ramsay MA et al. (2016) International Liver Transplant Society Practice Guidelines: Diagnosis and Management of Hepatopulmonary Syndrome and Portopulmonary Hypertension. Transplantation 100 (7):1440-52. DOI:10.1097/TP.0000000000001229 PMID: 27326810